Teva: Ledger

Stories naming Teva. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Investor	Rounds	Invested
No investors recorded yet. Know one?

Company	Kind	Announced	Price	Sources
Teva is not recorded as having acquired anything.

News

GBS Ventures achieves its 4th New Drug Approval from the US FDA

GBS Ventures marks its fourth FDA drug approval as Hatchtech's head lice treatment Xeglyze clears the regulator, recalling earlier wins behind Picato, Synribo and Aridol with Australian biotech firms.

GBS Ventures Mon 3 Aug 2020 Chemgenex GBS Ventures Hatchtech Leo Pharmaceuticals Peplin Inc Pharmaxis Teva University of Melbourne Dr Andrew Baker Ben Gust Brigitte Smith Hugh Alsop Professor Vern Bowles

Teva

Funding history

Investors

What Teva bought

People

Coverage

GBS Ventures achieves its 4th New Drug Approval from the US FDA